Sign in

Private company

Global Cord Blood Corp

Misc health and allied services company1

In its 2022 annual report (Form 20-F) the company says: “We are a Cayman Islands company registered by way of continuation in the Cayman Islands on June 30, 2009. Our corporate affairs are governed by our amended and restated memorandum and articles of association, the Companies Act (Revised) of the Cayman Islands and the common law of the Cayman Islands.”16

Last updated Oct 21, 2026.

Overview

$196.1MRevenue, fiscal 20222
$79.0MNet income, fiscal 20222
  • IndustryServices-Misc Health & Allied Services, NEC1
  • Business address48 Fl., Bank Of China Tower, 1 Garden Road, Central Hong Kong3
  • Filer categoryAccelerated filer3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

85.3%Gross margin2
49.0%Operating margin2
40.3%Net margin2
10.8%Revenue growth, 20222
10.3%Return on equity2
$93.7MFree cash flow2

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue15¢$28.9M
  • Research and development2¢$3.5M
  • Other costs34¢$66.0M
  • Income tax10¢$18.7M
  • Profit40¢$79.0M

Out of $196.1M in revenue.2

Where each dollar of operating cash went, fiscal 2022

  • Capital spending3¢$3.1M
  • Kept or used elsewhere97¢$93.7M

Out of $96.8M of cash from operations.2

Financial statements

Revenue4562$196.1M in 2022+33% since 2019
0$50.0M$100.0M$150.0M$200.0M2019: $147.0M$147.0M20192020: $172.5M$172.5M2020+17%2021: $177.0M$177.0M2021+3%2022: $196.1M$196.1M2022+11%
Gross profit789104562$167.2M in 2022+105% since 2015
0$50.0M$100.0M$150.0M$200.0M2015: $81.4M$81.4M20152016: $80.4M$80.4M2016−1%2017: $89.7M$89.7M2017+12%2018: $120.4M$120.4M2018+34%2019: $119.3M$119.3M2019−1%2020: $145.8M$145.8M2020+22%2021: $149.7M$149.7M2021+3%2022: $167.2M$167.2M2022+12%
Operating income789104562$96.0M in 2022+153% since 2015
0$25.0M$50.0M$75.0M$100.0M2015: $37.9M$37.9M20152016: $29.7M$29.7M2016−22%2017: $38.5M$38.5M2017+30%2018: $44.6M$44.6M2018+16%2019: $56.9M$56.9M2019+27%2020: $79.0M$79.0M2020+39%2021: $83.2M$83.2M2021+5%2022: $96.0M$96.0M2022+15%
Net income789104562$79.0M in 2022+357% since 2015
0$20.0M$40.0M$60.0M$80.0M2015: $17.3M$17.3M20152016: $14.1M$14.1M2016−18%2017: $18.3M$18.3M2017+30%2018: $37.8M$37.8M2018+106%2019: $43.4M$43.4M2019+15%2020: $66.5M$66.5M2020+53%2021: $77.6M$77.6M2021+17%2022: $79.0M$79.0M2022+2%
Fiscal year20152016201720182019202020212022
Revenue$147.0M4$172.5M5$177.0M6$196.1M2
Cost of revenue$27.7M4$26.7M5$27.3M6$28.9M2
Gross profit$81.4M7$80.4M8$89.7M9$120.4M10$119.3M4$145.8M5$149.7M6$167.2M2
Research and development$1.6M7$1.4M8$1.5M9$2.0M10$2.2M4$3.0M5$3.6M6$3.5M2
Operating expenses$71.2M2
Operating income$37.9M7$29.7M8$38.5M9$44.6M10$56.9M4$79.0M5$83.2M6$96.0M2
Interest$16.3M7$16.7M8$17.3M9$519.0K10
Income before tax$99.0M2
Income tax$7.6M7$7.8M8$5.5M9$10.0M10$9.1M4$14.3M5$14.4M6$18.7M2
Net income$17.3M7$14.1M8$18.3M9$37.8M10$43.4M4$66.5M5$77.6M6$79.0M2
Earnings per share$0.227$0.198$0.239$0.3310$0.364$0.555$0.646$0.652
Earnings per share (diluted)$0.227$0.198$0.239$0.3210$0.364$0.555$0.646$0.652
Shares (weighted, basic)121.6M shares2

Compare Global Cord Blood Corp with another company

Corporate structure

Global Cord Blood Corp sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Global Cord Blood Corp

  • Global Cord Blood Corp

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Global Cord Blood Corp reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$146.7M2 Mar 31, 2022$139.9M6 Mar 31, 2021+4.8%
Accumulated depreciation$71.9M2 Mar 31, 2022$63.8M6 Mar 31, 2021+12.7%
Property and equipment, net$74.7M2 Mar 31, 2022$76.1M6 Mar 31, 2021−1.8%
Operating-lease assets (leased space)$454.0K2 Mar 31, 2022$769.0K6 Mar 31, 2021−41.0%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$1.1B2 Mar 31, 2022$927.3M6 Mar 31, 2021+13.3%
Marketable securities, non-current$14.7M2 Mar 31, 2022$18.0M6 Mar 31, 2021−18.3%

Intangibles and goodwill

ItemLatestA year beforeChange
Intangible assets, net (excluding goodwill)$13.2M2 Mar 31, 2022$13.5M6 Mar 31, 2021−2.1%
Finite-lived intangibles, gross$21.9M2 Mar 31, 2022$21.2M6 Mar 31, 2021+3.4%
Accumulated amortization$8.7M2 Mar 31, 2022$7.7M6 Mar 31, 2021+12.8%
Finite-lived intangibles, net$13.2M2 Mar 31, 2022$13.5M6 Mar 31, 2021−2.1%

Inventory

ItemLatestA year beforeChange
Inventory, total$7.2M2 Mar 31, 2022$6.8M6 Mar 31, 2021+7.1%

Former names

  • China Cord Blood CorpJul 7, 2009 to Mar 16, 20183

Filings

68 filings to the SEC since October 2021: 1 annual reports, 20 large holders, 47 other. The latest 20:

  1. Sep 3, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  2. Aug 12, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  3. Jun 4, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  4. Mar 3, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  5. Dec 3, 20256-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  6. Sep 2, 20256-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  7. Aug 14, 2025NT 20-F EDGAR
  8. Jun 3, 20256-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  9. May 15, 2025SCHEDULE 13G/A EDGAR
  10. Mar 4, 20256-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  11. Feb 12, 20256-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  12. Dec 3, 20246-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  13. Sep 4, 20246-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  14. Aug 9, 2024NT 20-F EDGAR
  15. Jul 26, 20246-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  16. Jul 19, 20246-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  17. Jun 4, 20246-K/A REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  18. Jun 4, 20246-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  19. May 31, 20246-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  20. Apr 25, 20246-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR

The 68 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Global Cord Blood Corp is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARGlobal Cord Blood Corp1
  • CIK0001467808
  • Filer statusAccelerated filer1
  • Industry code (SIC)8090 Services-Misc Health & Allied Services, NEC1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address48 Fl., Bank Of China Tower, 1 Garden Road, Central Hong Kong, Hong Kong1
  • Phone852-3605-81801
  • Shares outstanding121,551,075 as of Mar 31, 20222
  • On EDGAR sinceJul 7, 20091
  • Filings397 in all: 6-K (147), SC 13D/A (52), 4 (38), SC 13G/A (24), CORRESP (21), UPLOAD (19), 20-F (14), 6-K/A (13)1
    All 31 form types

    SC 13D (9), 3 (8), EFFECT (8), F-3 (5), SC 13G (5), F-1/A (4), F-3/A (4), NT 20-F (4), 4/A (3), 424B3 (3), 20-F/A (2), POS AM (2), SC TO-I/A (2), 25-NSE (1), 424B4 (1), 8-A12B (1), CERTNYS (1), CT ORDER (1), F-1 (1), SC TO-C (1), SC TO-I (1), SCHEDULE 13G/A (1), SP 15D2 (1)

  • Latest filingsAnnual report (20-F) Aug 16, 2022

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16